Microbiology

Amicoumacin A is an orally active antibiotic that targets bacterial ribosomes, inhibiting translation by stabilizing the interaction between mRNA and ribosomes. This compound exhibits potent antibacterial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, as well as pathogens such as Salmonella, Shigella, and Helicobacter pylori. Additionally, Amicoumacin A has demonstrated anti-inflammatory and anti-ulcer properties, making it suitable for research in lung and breast cancer, bacterial infections, inflammatory edema, and gastric ulcer studies.

2-Hydroxygentamicin B1 is a 3-aminoglycoside antibiotic that targets bacterial protein synthesis by inhibiting the 30S ribosomal subunit. It exhibits broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is primarily used in research applications focusing on antibiotic resistance and the mechanisms of bacterial infections.

Arylomycin B6 is a lipohexapeptide antibiotic that targets Gram-positive bacteria. It exhibits potent antimicrobial activity, making it a valuable reagent for research focusing on bacterial infection mechanisms and resistance. This compound serves as a critical tool in the development of novel antibacterial therapies and contributes to the understanding of peptide antibiotics in microbiology.

1-Hydroxyauramycin A is an anthracycline antibiotic that primarily targets tumor cells. It exhibits significant antitumor activity and is also effective against Gram-positive bacteria. This compound is utilized in research for its potential applications in cancer therapy, as well as in studies related to bacterial resistance.

Glidobactin B is an antitumor antibiotic that exhibits potent activity against pathogenic fungi and yeast. This compound has been shown to enhance survival rates in mice inoculated with leukemia P388 cells, making it a valuable tool for research in cancer therapeutics and infectious disease. Its unique properties enable the exploration of potential treatments for various malignancies and fungal infections.

Chitinovorin A is a β-lactam antibiotic that exhibits selective antibacterial activity. Although it demonstrates weak inhibitory effects against Gram-negative bacteria, it may possess unique properties that warrant further exploration. This compound is suitable for research applications in studying antibiotic mechanisms and resistance patterns in microbial populations.

Actinoidin A is a glycopeptide antibiotic primarily targeting Gram-positive bacteria. It exhibits potent antimicrobial activity, making it a valuable tool in studies focused on bacterial resistance and antibiotic efficacy. Actinoidin A is applicable in research involving the development of new therapeutic strategies against Gram-positive infections.

Clavariopsin A is a cyclic depsipeptide antibiotic that exhibits potent antifungal activity against various strains of Candida and Aspergillus species. Specifically, it demonstrates minimum inhibitory concentrations (MIC) of 8 μg/mL for Candida albicans IFO 0583 and ATCC 10231, as well as 16 μg/mL against Aspergillus niger, 2 μg/mL for Aspergillus fumigatus AJ117190, and 4 μg/mL for Aspergillus fumigatus JCM1739. Clavariopsin A serves as a valuable tool for research focusing on fungal infections and antibiotic development.

RK-1441A is a pyrrolobenzodiazepine antibiotic that demonstrates potent antibacteriophage activity. This compound is utilized in research applications focusing on viral infections in bacterial systems. Its mechanism of action makes it a valuable tool for studying phage biology and the interactions between bacteriophages and their bacterial hosts.

Memnobotrin B is an antitumor antibiotic derived from Memnoniella echinata (JS6308). It demonstrates significant inhibitory effects on various cancer cell lines, including NCI-460, MCF7, and SF-268. This compound is valuable for research applications focused on evaluating its cytotoxicity and potential therapeutic effects in cancer studies.

31-Homorifamycin W is an antibiotic that targets bacterial ribosomes, disrupting protein synthesis. Isolated from Amycolatopsis mediterranei, it demonstrates significant antibacterial activity against various gram-positive bacteria. Research applications include studying mechanisms of antibiotic resistance and exploring novel therapeutic strategies for bacterial infections.

Sarubicin B is a quinone antibiotic that targets Gram-positive bacteria, exhibiting potent antibacterial activity. Isolated from the culture filtrate of Streptomyces strain JA 2861, Sarubicin B is effective in inhibiting the growth of various pathogenic Gram-positive microorganisms. This compound is of particular interest for research applications focused on antibiotic development and the study of bacterial resistance mechanisms.

Awamycin is an antitumor ansamycin antibiotic that primarily targets and inhibits Hsp90 (Heat shock protein 90). It exhibits potent cytotoxic activity against various cancer cell lines, making it a valuable tool for cancer research. Awamycin is utilized to study mechanisms of tumor growth and resistance, as well as to evaluate potential therapeutic strategies in oncology.

5-Hydroxy-9-methylstreptimidone is a glutarimide antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. This compound exhibits antimicrobial activity, making it valuable for studies related to bacterial resistance and antibiotic efficacy. Its biological properties facilitate research into antibiotic mechanisms and the development of new antimicrobial agents.

Milbemycin α11 is an antibiotic that exhibits potent anthelmintic and acaricidal activity. It primarily targets and disrupts the neuromuscular function of nematodes and mites, leading to their paralysis and death. This compound is useful in research applications involving parasitic infections and pest management in agricultural studies.

Resorcinomycin B is an antibiotic derived from Streptoverticillium roseoverticillatum, targeting bacterial cell wall synthesis. It exhibits potent antibacterial activity and is primarily utilized in the research of antimicrobial resistance and antibiotic development. Its unique mechanism of action makes it a valuable tool in microbiological studies and the investigation of novel therapeutic agents.

Himalomycin B is an anthraquinone antibiotic with a primary mechanism targeting bacterial cell growth. It exhibits strong antibacterial activity against Staphylococcus aureus, Escherichia coli, and Streptomyces vuridochromogenes. This compound is utilized in research applications focused on antimicrobial resistance and the development of novel antibiotic therapies.

Epithienamycin F is a carbapenem antibiotic that exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria. Its efficacy in inhibiting bacterial growth makes it a valuable tool for research in antibiotic resistance and the development of new antimicrobial therapies. Epithienamycin F can be utilized in studies focused on evaluating the pharmacodynamics of antibiotic compounds and understanding their mechanisms of action.

Elaiomycin is an anti-bacterial agent that exhibits activity against Gram-positive bacteria as well as certain anaerobic bacteria. Additionally, it demonstrates efficacy against the protists Eimeria tenella and Eimeria acervulina. This compound is valuable for research applications focused on bacterial infections and parasitic control.

2-Hydroxygentamicin C2 is an antibiotic targeting bacterial ribosomes, demonstrating potent activity against both Gram-positive and Gram-negative bacteria. This reagent is primarily utilized in microbiological research to study antibiotic resistance mechanisms and to evaluate the efficacy of antibacterial agents. Its broad-spectrum activity makes it a valuable tool for investigating bacterial infections and developing new therapeutic strategies.

Murepavadin is a 14-amino-acid cyclic peptide targeting lipopolysaccharide transport protein D, demonstrating potent antibiotic activity against Pseudomonas aeruginosa. With MIC50 and MIC90 values of 0.12 mg/L, Murepavadin is effective in combating this opportunistic pathogen. This compound is valuable for research into bacterial resistance mechanisms and the development of new therapeutic strategies.

Decatromicin B is a potent antibiotic with strong antibacterial activity against both Gram-positive and Gram-negative bacteria. It is isolated from the Actinomyces species, demonstrating efficacy in various microbial infections. This compound is valuable for research applications in antibiotic susceptibility testing and the development of new antimicrobial therapies.

Miyakamide A1 is an antitumor antibiotic that inhibits cellular growth. It demonstrates significant cytotoxicity against P388 tumor cells with an IC50 of 10.5 μg/mL. Additionally, Miyakamide A1 shows insecticidal properties and exhibits weak activity against Xanthomonas species, making it a useful reagent for studies in cancer research and plant pathology.

Platenomycin A0 is a macrolide antibiotic that targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable tool in the study of bacterial resistance mechanisms. Researchers can utilize Platenomycin A0 in assays aimed at understanding antimicrobial efficacy and developing new therapeutic strategies against Gram-positive infections.

Altromycin G is an antibiotic that selectively targets Gram-positive bacteria, exhibiting potent antibacterial properties. In addition to its antimicrobial action, Altromycin G demonstrates significant antitumor activity, making it a valuable reagent for research applications focused on both infectious disease and cancer biology.

Sannamycin C is an aminoglycoside antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits weak antibacterial activity against Gram-positive bacteria, making it a compound of interest in studies of antibiotic resistance and bacterial mechanisms. Sannamycin C can be utilized in research focused on the development of new antimicrobial agents and the evaluation of bacterial susceptibility.

Mutalomycin is a polyether antibiotic targeting Gram-positive bacteria, mycoplasma, and coccidia. It exhibits significant antibacterial and antiparasitic activity, making it a valuable tool for studies involving bacterial infections and coccidiosis. Its efficacy in inhibiting microbial growth supports its application in microbiological research and the development of therapeutic interventions.

Piericidin B is an antibiotic targeting bacterial cells with potent antimicrobial properties. It exhibits strong antibacterial activity, making it a valuable tool in the study of antibacterial mechanisms and the development of new antibiotic therapies. Research applications include assessing its efficacy against various bacterial strains and understanding its role in natural antibiotic production.

Endophenazine B is a phenazine antibiotic primarily known for its antibacterial properties. It exhibits low herbicidal activity against the aquatic plant Lemna minor, making it a useful tool for studying microbial interactions and plant-pathogen dynamics. This compound serves as a valuable research agent for investigations into antibiotic efficacy and resistance mechanisms.

4'-Acetyl-chrysomycin A, an analog of chrysomycin A, primarily targets bacterial cellular processes. This compound exhibits significant antibacterial activity, making it a valuable tool for antimicrobial research. Its applications include the study of antibacterial mechanisms and potential therapeutic development against bacterial infections.

Porothramycin A is an antibiotic that primarily targets Gram-positive and anaerobic bacteria. It exhibits significant antibacterial activity, making it a valuable compound for research focused on bacterial infections and antibiotic resistance. This reagent is suitable for studies aimed at understanding microbial pathogenesis and developing novel antimicrobial therapies.

S-2,3-Dicarboxyaziridine is an antibacterial agent derived from metabolites isolated from Streptomyces species. It exhibits significant antibacterial activity, making it an important compound for research focused on microbial infections and antibiotic development. This reagent can facilitate investigations into the efficacy and mechanisms of new antibacterial therapies.

Polymyxin A1 is a heteropeptide antibiotic that primarily targets the outer membrane of Gram-negative bacteria. It exhibits significant antibacterial activity, making it an important reagent in studying bacterial membrane dynamics and resistance mechanisms. Its selective efficacy against Gram-negative pathogens positions Polymyxin A1 as a valuable tool in microbiological research and antibiotic development.

23-De(mycinosyloxy)tylosin is a macrolide antibiotic that primarily targets Gram-positive bacteria. It exhibits antibacterial activity against a range of both Gram-positive and mycoplasma species, while showing limited effectiveness against Gram-negative bacteria. This compound is utilized in microbiological research to study antibiotic resistance and the mechanisms of bacterial inhibition.

Maridomycin V is a macrolide antibiotic that targets Gram-positive bacteria and mycoplasma. It exhibits potent antibacterial activity, demonstrating efficacy in protecting murine models from Gram-positive bacterial infections. This compound is valuable for research applications focusing on antibacterial activity and the mechanisms of resistance in Gram-positive pathogens.

Permetin A is a peptide antibiotic that exerts its antibacterial effects by targeting and disrupting bacterial cell membranes. This compound demonstrates significant activity against Gram-negative bacteria, Gram-positive bacteria, and anaerobic bacteria, making it a valuable tool for researchers studying bacterial resistance mechanisms and developing new antimicrobial therapies. Its broad-spectrum efficacy positions Permetin A as a potent candidate for further exploration in the field of microbiological research.

7β,8β-2′,3′-Diepoxyroridin H is an antibiotic that exhibits activity against both Gram-positive and Gram-negative bacteria. Its broad-spectrum efficacy makes it a valuable tool for studying bacterial resistance mechanisms and antibiotic susceptibility in various research applications.

Depsidomycin is an immunomodulating antibiotic that exhibits immunosuppressive activity. Isolated from Streptomyces lavendofoliae MI951-62F2, it demonstrates potent antibacterial effects against Gram-positive bacteria. This compound is valuable for research applications focusing on the modulation of immune responses and the inhibition of bacterial growth.

Halomicin B is an ansamycin antibiotic that targets bacterial RNA polymerase, inhibiting transcription. It exhibits antimicrobial activity against a variety of Gram-positive and Gram-negative bacteria, making it a valuable reagent for studies involving bacterial infections. Its efficacy in selectively disrupting bacterial growth positions Halomicin B as a critical tool in antibiotic research and development.

Aurein 2.1 is an antibiotic peptide derived from the skin secretions of Australian Bell Frogs, specifically Litoria aurea and Litoria raniformis. It exhibits significant antimicrobial activity against a range of bacterial strains, making it a valuable tool for research in antibiotic development and investigations into novel antimicrobial mechanisms. This peptide is of particular interest for studies related to infection control and the exploration of natural antimicrobial agents.

Cytosaminomycin A is an antibiotic that exhibits potent anticoccidial and antibacterial activities. This compound is utilized in research studies to explore its efficacy against various pathogens, making it valuable in the field of microbiology and infectious disease research. Its unique mechanisms may provide insights into antibiotic resistance and potential therapeutic applications.

Epoxyquinomicin A is an antibiotic derived from the bacterium Amycolatopsis sp., exhibiting significant antimicrobial activity against various pathogens including Micrococcus luteus, Bacillus subtilis, Pasteurella piscicida, and Staphylococcus aureus, with minimum inhibitory concentrations (MIC) ranging from 3 to 12.5 µg/mL. Additionally, Epoxyquinomicin A demonstrates cytotoxic effects on cancer cell lines such as L1210, B16, and S180, with IC50 values between 2 and 8 µg/mL. Its anti-inflammatory properties have also been noted, particularly in models of collagen-induced arthritis, making it a valuable reagent for research in microbiology and oncology.

Mycinamicin VII is a macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. It demonstrates significant antibacterial activity against Gram-positive bacteria, making it a valuable tool for research in microbiology and antimicrobial therapy. Its efficacy in inhibiting the growth of various pathogenic strains underscores its potential for further investigation in antibiotic resistance studies.

Bactobolin hydrochloride is an antibiotic that exhibits potent inhibitory activity against a range of gram-negative and gram-positive bacteria, including Escherichia coli, Salmonella, Shigella, Staphylococcus, and Bacillus subtilis, with minimum inhibitory concentrations (MICs) ranging from 0.3 to 6.25 μg/mL. Additionally, Bactobolin hydrochloride demonstrates antitumor activity against leukemia, showing a median lethal dose (LD50) of 6.25 to 12.5 mg/kg. This compound is valuable for research in microbiology and cancer therapeutics.

Clavamycin F is a clavam antibiotic that inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins. It demonstrates significant antibacterial activity against a range of Gram-positive bacteria. This compound is utilized in research applications aimed at understanding antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections.

3-O-α-D-Forosaminyl-(+)-griseusin is a naphthoquinone antibiotic that primarily targets Gram-positive bacteria. It exhibits potent activity against various strains, including methicillin-resistant Staphylococcus aureus (MRSA). This compound serves as an important tool in antimicrobial research and the development of new therapeutic strategies against resistant bacterial infections.

Griseusin B is a quinone antibiotic that primarily targets Gram-positive bacteria. Its significant antibacterial activity makes it a valuable tool in research focused on infectious diseases and antibiotic resistance mechanisms. Griseusin B can be utilized to study bacterial susceptibility and the effects of antibiotic treatment in various biological systems.

L-threo-β-Hydroxyaspartic acid is an amino acid antibiotic that targets bacterial cell metabolism. It has demonstrated efficacy in inhibiting the growth of several pathogens, including Bacillus subtilis, Xanthomonas oryzae, Mycobacterium phlei, and Botrytis cinerea. This compound is valuable for research applications focused on microbiology and antibiotic resistance studies.

Argimicin A is an antibiotic isolated from Sphingomonas sp. It demonstrates significant algicidal activity against toxic cyanobacteria and effectively inhibits Microcystis viridis and Microcystis aeruginosa, with IC50 values of 12 ng/mL and 100 ng/mL, respectively. This compound is valuable for research on algal blooms and the study of antibiotic mechanisms in aquatic environments.

Amythiamicin B is a trisubstituted pyridine thiopeptide that functions as an antibiotic primarily targeting Gram-positive bacteria. Additionally, it exhibits activity against Plasmodium falciparum, making it relevant for research on malaria. Its unique structural attributes allow it to be a valuable tool in the study of antimicrobial resistance and the development of new therapeutic strategies.